Figure 3

T-cell-mediated antitumour activity of PBMCs of glioma patients, as evaluated by the ELISPOT assay before and after vaccination. Data are shown as the median values±standard deviation (n=3). Statistical significance was assessed by Student's t-test. *P<0.05.